Oprah Daily on MSN
There is an effective surgical treatment for Parkinson’s. Why aren’t more women with the disease getting it?
Deep brain stimulation, or DBS, is like a pacemaker for the brain—and can hugely improve symptoms. Here is everything you need to know.
Marshall University and Marshall Health Network, in collaboration with Intermed Labs (IL), has launched a new medical technology development initiative focused on improving the precision and safety of ...
Loop Stimulation Systems, and Personalized Neuromodulation Therapies Accelerating Market Expansion.Austin, United States, March 11, 2026 (GLOBE NEWSWIRE) -- Deep Brain Stimulation Devices Market Size ...
ABP Live Doc Talk: Rethinking Parkinson’s Treatment Through Patient Experience And Recovery Outcomes
Parkinson’s treatment is shifting beyond symptom control toward improving quality of life, as emerging incision-free ...
About a decade ago, Joan Riggs, a 64-year-old from Lemoyne, started to have shaky hands. At first, it was an annoyance.
Speculation about Bill Clinton’s health has sparked renewed interest in Parkinson’s disease, a progressive neurological disorder affecting movement. Viral clips showing hand tremors have fueled online ...
For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an appliance can be difficult. In recent years, companies like Cala Health and ...
BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. This press ...
(RTTNews) - Praxis Precision Medicines, Inc. (PRAX) on Monday said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to ulixacaltamide for the treatment of patients ...
Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor. Praxis on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results